Martin Kenworthy, PhD

Principal Scientist, Chemical Development at AstraZeneca

Speaker

Martin Kenworthy is a Principal Scientist in the New Modalities Unit in Chemical Development at AstraZeneca. Martin studied Chemistry at University of Manchester (UK) and obtained his Ph.D. in 2003 with Prof. Jonathan Clayden. After postdoctoral studies with Prof. Richard Taylor at York University (UK), he joined AstraZeneca in 2006 (Macclesfield, UK), where he works in Chemical Development. Over the last decade, he has been responsible for AZ drug substance development for late clinical stage and commercial peptide projects and products. Including delivery of successful process development and validation, plus technical content of regulatory submissions. He has also engaged in cross-industry consortia including ACS Green Chemistry Institute Pharmaceutical Roundtable, Peptide sub-team and IQ CMC peptide teams.